Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML)Completed
NCT01422603Phase 1, Phase 2Updated Sep 7, 2018
Sponsor: University Hospital Southampton NHS Foundation Trust
Acute Myeloid Leukaemia · Myelodysplasia
United Kingdom
SR-45023A in Treating Patients With Advanced Solid TumorsCompleted
NCT00003822Phase 1Updated Aug 29, 2018
Sponsor: Genzyme, a Sanofi Company
Unspecified Adult Solid Tumor, Protocol Specific
United States
Chemotherapy in Treating Patients With Advanced or Metastatic Solid TumorsCompleted
NCT00003713Phase 1Updated Aug 29, 2018
Sponsor: Genzyme, a Sanofi Company
Unspecified Adult Solid Tumor, Protocol Specific
United States, Canada
SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompleted
NCT00004049Phase 1Updated Aug 29, 2018
Sponsor: Genzyme, a Sanofi Company
Unspecified Adult Solid Tumor, Protocol Specific
United States
Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study ProgrammeCompleted
NCT01809015N/AUpdated Aug 24, 2018
Sponsor: Johannes Gutenberg University Mainz
Anticoagulant Antagonists, Vitamin K and Other Coagulants Causing Adverse Effects in Therapeutic Use · Atrial Fibrillation · Venous Thromboembolism
Germany
Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the UterusCompleted
NCT00476086Phase 2Updated Aug 24, 2018
Sponsor: Dana-Farber Cancer Institute
Mixed Mullerian Tumors of the Uterus
United States
A Study of SAR428926 in Patients With Advanced Solid TumorsCompleted
NCT02575781Phase 1Updated Aug 22, 2018
Sponsor: Sanofi
Neoplasm Malignant
Denmark, France, Spain
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)Completed
NCT01024998Phase 1Updated Aug 22, 2018
Sponsor: Genzyme, a Sanofi Company
Macular Degeneration · Age-Related Maculopathies · Age-Related Maculopathy · Maculopathies, Age-Related
United States
Follow up of Thai Adult Volunteers With Breakthrough HIV Infection After Participation in a Preventive HIV Vaccine TrialCompleted
NCT00337181N/AUpdated Aug 22, 2018
Sponsor: U.S. Army Medical Research and Development Command
HIV-1
Thailand
Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin RegimenCompleted
NCT02287532NAUpdated Aug 21, 2018
Sponsor: Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
Diabetes
France
Treatment of Severe Infection With Antihyperlipidemia DrugUnknown
NCT03634293Phase 2, Phase 3Updated Aug 16, 2018
Sponsor: Wolfson Medical Center
Sepsis · Septic Shock
Israel
Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)Terminated
NCT01690325Phase 2Updated Aug 13, 2018
Sponsor: Women's Cancer Study Group GmbH
Breast Cancer
Germany
Study of Dupilumab in Adult Patients With Extrinsic Moderate-to-Severe Atopic DermatitisCompleted
NCT01548404Phase 2Updated Aug 10, 2018
Sponsor: Regeneron Pharmaceuticals
Atopic Dermatitis
Czechia, France, Germany, Hungary, Poland
Effects of IAS in Men With Localized Biochemical Relapsed Prostate CancerCompleted
NCT00223665Phase 2Updated Aug 7, 2018
Sponsor: University of Washington
Prostate Cancer
United States
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic DermatitisCompleted
NCT03050151Phase 1Updated Aug 1, 2018
Sponsor: Regeneron Pharmaceuticals
Atopic Disorders · Eczema, Atopic
United States
Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)Completed
NCT02023879Phase 3Updated Jul 27, 2018
Sponsor: Sanofi
Hypercholesterolemia
United States, Australia, Belgium, Canada, Denmark +3 more
Open Label Study of Long Term Safety Evaluation of AlirocumabCompleted
NCT01954394Phase 3Updated Jul 24, 2018
Sponsor: Sanofi
Hypercholesterolemia
United States, Argentina, Austria, Belgium, Bulgaria +19 more
Epidemiological Study of Fabry Disease in Taiwan Young Stroke PatientsUnknown
NCT03596398N/AUpdated Jul 23, 2018
Sponsor: Chiayi Christian Hospital
Fabry Disease
Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in AdultsCompleted
NCT01230957Phase 2Updated Jul 18, 2018
Sponsor: Sanofi Pasteur, a Sanofi Company
Clostridium Difficile Infection · Diarrhea
United States
Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in JapanCompleted
NCT01896830Phase 1, Phase 2Updated Jul 18, 2018
Sponsor: Sanofi Pasteur, a Sanofi Company
Clostridium Difficile Infection
Japan
Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ VaccineCompleted
NCT00258882N/AUpdated Jul 17, 2018
Sponsor: Sanofi Pasteur, a Sanofi Company
Pertussis
United States
ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male VolunteersCompleted
NCT01483911Phase 1Updated Jul 13, 2018
Sponsor: Ablynx, a Sanofi company
RSV Infection
Netherlands
ALX-0171 Phase I Pharmacokinetic Study in Healthy Male VolunteersCompleted
NCT01875926Phase 1Updated Jul 13, 2018
Sponsor: Ablynx, a Sanofi company
Healthy · RSV Infection
Belgium
ALX-0171 Safety Study in Adults With Hyperresponsive AirwaysCompleted
NCT01909843Phase 1Updated Jul 13, 2018
Sponsor: Ablynx, a Sanofi company
Respiratory Syncytial Virus Infection
Germany
Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML)Completed
NCT01352650Phase 1Updated Jul 2, 2018
Sponsor: Weill Medical College of Cornell University
Acute Myeloid Leukemia
United States

Previous page Next page